# The Role of Inflammatory Processes in Development and Treatment of Depression

> **NCT03920475** · — · COMPLETED · sponsor: **Kliniken Essen-Mitte** · enrollment: 104 (actual)

## Conditions studied

- Depressive Disorder
- Depression
- Inflammation

## Interventions

- **DRUG:** Sertraline or venlafaxine
- **DIAGNOSTIC_TEST:** Immune parameters

## Key facts

- **NCT ID:** NCT03920475
- **Lead sponsor:** Kliniken Essen-Mitte
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-05
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-03-06
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2020-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920475, "The Role of Inflammatory Processes in Development and Treatment of Depression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03920475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*